Ссылки

DOI

  • Valentina K. Bayrasheva
  • Alina Yu Babenko
  • Vladimir A. Dobronravov
  • Yuri V. Dmitriev
  • Svetlana G. Chefu
  • Ivan Yu Pchelin
  • Alexandra N. Ivanova
  • Alekber A. Bairamov
  • Nina P. Alexeyeva
  • Ivan S. Shatalov
  • Elena N. Grineva

Type 2 diabetes (DM2) could be reproduced in rats with alimentary obesity by using low doses of streptozotocin (LD-STZ) as well as STZ in high doses with preliminary nicotinamide (NA) administration. However, STZ could induce tubulotoxicity. Aim. To develop rat model of DN in NA-STZ-induced DM2 and compare it with LD-STZ-model in order to choose the most relevant approach for reproducing renal glomerular and tubular morphofunctional diabetic changes. Starting at 3 weeks after uninephrectomy, adult male Wistar rats were fed five-week high-fat diet and then received intraperitoneally either LD-STZ (40 mg/kg) or NA (230 mg/kg) followed by STZ (65 mg/kg). Control uninephrectomized vehicle-injected rats received normal chow. At weeks 10, 20, and 30 (the end of the study), metabolic parameters, creatinine clearance, albuminuria, and urinary tubular injury markers (NGAL, KIM-1) were evaluated as well as renal ultrastructural and light microscopic changes at weeks 20 and 30. NA-STZ-group showed higher reproducibility and stability of metabolic parameters. By week 10, in NA-STZ-group NGAL level was significantly lower compared to LD-STZ-group. By week 30, diabetic groups showed early features of DN. However, morphofunctional changes in NA-STZ-group appeared to be more pronounced than those in STZ-group despite lower levels of KIM-1 and NGAL. We proposed a new rat model of DM2 with DN characterized by stable metabolic disorders, typical renal lesions, and lower levels of tubular injury markers as compared to LD-STZ-induced diabetes.

Язык оригиналаанглийский
Номер статьи8317850
Число страниц18
ЖурналJournal of Diabetes Research
Том2016
Номер выпускаArticle ID 8317850
DOI
СостояниеОпубликовано - 2016

    Предметные области Scopus

  • Эндокринология, диабет и метаболизм
  • Эндокринология

ID: 7642817